New Enterprise Associates 15, L.P. → OnKure Therapeutics, Inc. OKUR

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 1.00

163,904 shares short · +1958.6% vs prior

Other 13D/G Filings on OnKure Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-04-07	SCHEDULE 13D	AI Biotechnology LLC	19.99%	9,091,532	view →
2025-01-21	SCHEDULE	RiverVest Venture Fund III, L.P.	1.55%	196,198	view →

Other Filings by New Enterprise Associates 15, L.P.

Filed	Form	Issuer	Stake	Shares
2025-03-10	SCHEDULE	Senti Biosciences, Inc. SNTI	14.50%	3,775,615	view →
2021-06-03	SC	Eargo, Inc.	—	—	view →
2021-04-13	SC	Millendo Therapeutics, Inc. TPST	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →